Location History:
- Brookline, MA (US) (2008)
- Seattle, WA (US) (2020 - 2022)
Company Filing History:
6 out of 19 
1 out of 1,210 
1 out of 389 
Years Active: 2008-2022
Title: Yvette Latchman: Innovator in Immunotherapy
Introduction
Yvette Latchman is a prominent inventor based in Seattle, WA, known for her significant contributions to the field of immunotherapy. With a total of seven patents to her name, she has made remarkable strides in developing methods and compositions that enhance immune responses.
Latest Patents
Among her latest patents are innovative techniques for combination immunotherapy. One patent focuses on methods for generating immune responses using adenovirus vectors, which allow for multiple vaccinations even in individuals with preexisting immunity to adenovirus. Another notable patent involves combination immunotherapies that utilize IL-15 superagonists, providing methods and compositions for generating enhanced immune responses through adenovirus vectors in conjunction with an IL-15 superagonist complex.
Career Highlights
Throughout her career, Yvette has worked with esteemed organizations such as Etubics Corporation and Dana-Farber Cancer Institute. Her work has been pivotal in advancing the understanding and application of immunotherapy in clinical settings.
Collaborations
Yvette has collaborated with notable professionals in her field, including Frank R. Jones and Adrian Rice. These partnerships have contributed to her innovative research and development efforts.
Conclusion
Yvette Latchman stands out as a leading inventor in the realm of immunotherapy, with her patents reflecting her dedication to improving health outcomes through innovative approaches. Her work continues to inspire advancements in medical science.